Lampalizumab offers realistic hope for atrophic AMD

Lampalizumab offers realistic hope for atrophic AMD

Gene mutations lead to overactivation of the complement pathway and to “an abnormal, constant anti-inflammatory reaction,” which destroys normal cells, Monés explained. Lampalizumab inhibits the complement factor D, thus interfering with the activation

(Visited 9 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.